Skip to main content

Oxana Beskrovnaya Ph.D.

Equibles does not estimate personal net worth.

Get an email with a short summary when Dyne Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get DYN alerts

About Oxana Beskrovnaya Ph.D.

Dyne Therapeutics, Inc. reported in an 8-K filed June 2, 2021 that Oxana Beskrovnaya Ph.D. was appointed Chief Scientific Officer, effective June 2, 2021. Dyne Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Dyne Therapeutics, Inc. includes John G. Cox (CEO and Board Member), Josh Brumm (CEO), Erick Lucera (CFO and Chief Accounting Officer) and 4 others.

“Upon the Resignation Date, Oxana Beskrovnaya Ph.D., the Company’s Senior Vice President, Head of Research, was appointed Chief Scientific Officer of the Company.”
Dyne Therapeutics, Inc. Form 8-K, filed June 2, 2021 · Read the filing

Affiliation history

Company network

Leadership on record at Dyne Therapeutics, Inc.

Recent activity